Stomach Cancer Diagnosis and Staging Explained

A stomach cancer diagnosis leaves most people with one urgent question: how serious is it? The answer depends on your stage - a single word that shapes every treatment conversation ahead. Knowing what staging is and how your doctor figures it out helps you ask better questions and weigh your options.

This guide is for people newly diagnosed with stomach cancer or helping a family member through diagnosis. It explains the tests doctors use, how the TNM staging system works, what each stage means for treatment, and why biomarker testing matters.

What is stomach cancer?

Stomach cancer (also called gastric cancer) starts when cells in the stomach lining grow out of control. The most common type is adenocarcinoma, which starts in the gland cells that line the stomach. The cell type matters because it determines which treatments your oncologist will consider.

According to the American Cancer Society, men are diagnosed more often than women, and people over 65 get it more often. Rates vary by region - stomach cancer is far more common in East Asia, Eastern Europe, and South America than in North America or Western Europe.

What tests confirm the diagnosis and stage?

Before recommending treatment, your doctors need to know two things: what kind of cancer it is and how far it has spread. Here's what you'll go through after diagnosis:

1. Endoscopy with biopsy. A thin tube with a camera (called an endoscope) goes through your mouth into your stomach. If they see anything abnormal, they take a tissue sample (called a biopsy). A pathologist examines these cells under a microscope to confirm the cancer type and grade.
2. CT scan. A CT scan takes cross-section images using X-rays. Your doctors use it to check the tumor size and whether cancer has reached nearby lymph nodes or distant organs like the liver or lungs.
3. Endoscopic ultrasound (EUS). An ultrasound probe on the endoscope sends sound waves through the stomach wall. This shows how deep the tumor has grown through the wall layers - detail that a standard CT scan often misses. The National Cancer Institute says EUS is key for local staging.
4. PET-CT scan (in some cases). A PET scan uses a tiny amount of radioactive glucose to highlight highly active cells - which cancer cells are. Not every patient needs one, but it can find spread that CT alone might miss. For more on what a PET-CT involves, see the HealthUnwired guide on understanding PET-CT scans in cancer diagnosis.
5. Laparoscopy (in some cases). A surgeon makes a small cut and inserts a thin camera to look directly for spread the scans may not detect - especially in the abdominal lining. It's done under general anesthesia and isn't always needed.

Your doctors won't necessarily order all five. Which tests you need depends on the initial results and how advanced the tumor is locally.

How stomach cancer is staged: the TNM system

Once results are in, your doctor assigns a stage using the TNM system - short for Tumor, Nodes, and Metastasis. According to the National Cancer Institute's staging guide:

• T (Tumor) shows how far the tumor has grown through the stomach wall layers. T1 means the cancer is still in the inner layers. T4 means it has broken through the outer wall and may have reached nearby organs.
• N (Nodes) shows whether cancer has reached nearby lymph nodes - small glands that fight infection. N0 means no nodes are involved. N3 means many nodes have cancer.
• M (Metastasis) shows whether cancer has spread to distant organs like the liver, lungs, or abdominal lining. M0 means no distant spread was found. M1 means it has spread.

These three measurements combine to give you an overall stage: I, II, III, or IV. Stage I is the most localized. Stage IV means the cancer has spread far beyond the stomach and nearby lymph nodes. For more on how TNM staging works for all cancer types, see the HealthUnwired guide on cancer staging and TNM classification.

What each stage generally means for treatment

Your stage is the starting point for every treatment conversation. The following is a general picture - your doctor will consider your overall health, where the tumor is, and your biomarker results before making a plan.

• Stage I. Surgery is usually the main option. The goal is to remove the tumor completely. Based on your T and N results, your doctor may also recommend chemotherapy before or after surgery.
• Stage II. Surgery is still an option, but chemotherapy is more often added - both before surgery (called neoadjuvant chemotherapy) and after. The goal is still to remove all the cancer.
• Stage III. The cancer has reached more lymph nodes or grown deeper into surrounding tissue. Surgery may still be possible for some patients. Your doctor may plan a combination of chemotherapy and sometimes radiation therapy before and after surgery. Whether all the cancer can be removed depends heavily on how the cancer has spread.
• Stage IV. When cancer has reached distant organs, surgery is usually not the main focus. Options include chemotherapy, targeted therapy, and immunotherapy - your specific plan depends mostly on biomarker results.

These are general patterns, not fixed rules. Two patients with the same stage can have very different treatment plans based on other factors your team considers.

Why biomarker testing matters before you commit to a plan

Biomarker testing (also called molecular testing) looks at specific features of cancer cells to predict which treatments might work. For stomach cancer, the test is done on tissue from your endoscopy biopsy. The results can change which treatment options you have.

Your team should test for these main biomarkers:

• HER2 status. HER2 is a protein that makes cancer cells grow faster when it's overproduced. About 10 to 20 percent of gastric cancers are HER2-positive. Your HER2 status matters because it determines whether targeted therapies can be added to your treatment.
• MSI/MMR status. Mismatch repair (MMR) is a system that corrects DNA errors. When it doesn't work right - called deficient mismatch repair (dMMR) or microsatellite instability-high (MSI-H) - the cancer may respond well to immunotherapy.
• PD-L1 expression. This protein helps cancer cells hide from the immune system. Higher PD-L1 levels may mean immunotherapy will work better.
• CLDN18.2 (Claudin 18.2). A newer biomarker doctors now test more often in advanced gastric cancer. New treatments work on tumors that have high levels of this protein.

A study found that testing for HER2, deficient mismatch repair, and Epstein-Barr virus status changed treatment decisions in 56 percent of patients with advanced gastric cancer. That's a big percentage - which is why it's crucial to ask your team whether all relevant biomarker tests have been ordered before you agree to a plan.

If you're not sure which tests were done or if your biopsy came from a hospital without a specialist gastrointestinal cancer program, a second opinion on the molecular results alone can help. Our guide on getting a second opinion on molecular testing explains what that process involves.

When a second opinion makes sense

A second opinion is a normal part of cancer care - not a sign of distrust in your doctor. For stomach cancer, a second review is worth considering if:

• You were diagnosed at a hospital without a dedicated gastrointestinal oncology team.
• Your treatment plan doesn't mention biomarker testing or you're not sure which tests were run.
• You've been told surgery isn't possible and you want a second opinion from a center that handles many gastric cancer cases.
• You're considering treatment in a different country and want an independent review of your records first.

Video consultations have made this process faster. You can upload your biopsy report, CT scans, endoscopy findings, and pathology results, and a specialist oncologist will review them and send a written opinion - usually within 48 hours - without travel. If you're exploring treatment abroad, the HealthUnwired guide on stomach cancer treatment in India for international patients covers specialist centers, costs, and logistics.

If you're managing this for a family member who is too sick to help, our article on what to do when a family member is too sick to decide covers how to take that role on.

Questions worth asking before treatment starts

Before you agree to any treatment plan, bring these questions to your oncology team:

• What is my exact stage, and what does each part of the TNM say about my cancer?
• Have all the recommended biomarker tests been ordered and are the results back?
• Is the goal to remove all the cancer or to control its growth?
• What happens if I skip one part of the plan - like chemotherapy before surgery?
• Are there clinical trials I might be eligible for?
• Should I see a specialist at a center that handles many stomach cancer cases before we start?

For a longer list to bring to your first appointment, see the HealthUnwired patient checklist for your first oncologist visit.

Managing the wait between diagnosis and your first full consultation

The time between diagnosis and your first full treatment consultation can feel long and unsettling. It's common to lose sleep, have trouble concentrating, and feel pulled to search online. If anxiety disrupts your sleep during this waiting period, talk to your doctor about options that might help.

Remember this: the staging workup takes time because your team needs the full picture before they can guide you accurately. A treatment plan based on complete information is almost always better than a rush job.

When to talk to your doctor

Contact your oncologist right away if you develop new or worsening symptoms while waiting for results - including significant weight loss, trouble swallowing, ongoing belly pain, or new swelling in your neck or belly. These may need immediate attention and shouldn't be ignored.

If you want an independent review of your diagnosis and treatment options, you can upload your reports and book a video consultation with a specialist at HealthUnwired. No travel required - a written oncologist report is usually ready within 48 hours.

This article is for general information and is not a substitute for medical advice. Always consult your oncologist or care team about your specific situation.